NexImmune, Inc. (28)
Browse by Contract Category
Contracts
-
First Amendment to Employment Agreement by and between the Registrant and Mathias Oelke, date August 11, 2022
(Filed With SEC on August 15, 2022)
-
Controlled Equity Offering Sales AgreementSM, dated June 17, 2022, by and among NexImmune Inc., Cantor Fitzgerald & Co. and BTIG, LLC
(Filed With SEC on June 17, 2022)
-
Joint Research Agreement, by and between Zephyr AI, Inc. and NexImmune, Inc., dated March 16, 2022
(Filed With SEC on May 12, 2022)
-
Second Amended and Restated Investors Rights Agreement, by and between the Registrant and the investors listed therein, dated November 27, 2019
(Filed With SEC on February 8, 2021)
-
Lease Agreement, by and between the Company and W. M. Rickman Construction Co., LLC, dated June 30, 2017
(Filed With SEC on January 19, 2021)
-
Amended and Restated Exclusive License Agreement, by and between the Johns Hopkins University and NexImmune, Inc., dated June 21, 2011
(Filed With SEC on January 19, 2021)
-
Employment Agreement, by and between the Registrant and Mathias Oelke, date April 5, 2022
(Filed With SEC on May 12, 2022)
-
Employment Agreement, by and between the Company and Kristi Jones, dated
(Filed With SEC on March 9, 2022)
-
Separation Agreement, dated February 12, 2022
(Filed With SEC on February 17, 2022)
-
Non-Employee Director Compensation Policy
(Filed With SEC on May 17, 2021)
-
Description of Securities
(Filed With SEC on March 31, 2021)
-
Employment Agreement, by and between the Registrant and John Trainer, dated January 6, 2020
(Filed With SEC on February 8, 2021)
-
Non-Employee Director Compensation Policy
(Filed With SEC on February 8, 2021)
-
Employment Agreement, by and between the Registrant and Robert Knight, M.D., dated January 6, 2021
(Filed With SEC on February 8, 2021)
-
Employment Agreement, by and between the Registrant and Kristi Jones, dated February 27, 2017
(Filed With SEC on February 8, 2021)
-
Employment Agreement, by and between the Registrant and Jerome Zeldis, M.D., Ph.D., dated January 4, 2021
(Filed With SEC on February 8, 2021)
-
Employment Agreement, by and between the Registrant and Scott Carmer, dated February 3, 2021
(Filed With SEC on February 8, 2021)
-
Form of Stock Option Agreement under the 2021 Equity Incentive Plan
(Filed With SEC on February 8, 2021)
-
2021 Equity Incentive Plan
(Filed With SEC on February 8, 2021)
-
Form of Stock Option Agreement under the 2018 Equity Incentive Plan, as amended
(Filed With SEC on February 8, 2021)
-
2018 Equity Incentive Plan, as amended
(Filed With SEC on February 8, 2021)
-
Form of Stock Option Agreement under the 2017 Equity Incentive Plan, as amended
(Filed With SEC on February 8, 2021)
-
2017 Equity Incentive Plan, as amended
(Filed With SEC on February 8, 2021)
-
Form of Indemnification Agreement
(Filed With SEC on February 8, 2021)
-
Form of Convertible Promissory Note, as amended
(Filed With SEC on February 8, 2021)
-
Form of Common Stock Certificate
(Filed With SEC on February 8, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on February 8, 2021)
-
Sublease Agreement, by and between the Company and Modavar Pharmaceuticals LLC, dated December 11, 2017
(Filed With SEC on January 19, 2021)
